by Jordana Choucair | Jan 13, 2022 | D.C. News
The Senate Health, Education, Labor, and Pensions committee is scheduled to vote today on Robert Califf’s nomination to lead the FDA. While the committee likely has the votes to pass his nomination, it is unclear if the full Senate will follow. Several Democrats –...
by Jordana Choucair | Jan 12, 2022 | D.C. News
The Biden administration announced today it is increasing the number of COVID-19 tests available to schools by 10 million per month. The administration plans to distribute 5 million free, rapid tests monthly to schools and will make lab capacity available to support...
by Jordana Choucair | Jan 12, 2022 | D.C. News
The Biden administration released new guidance instructing federal agencies to start testing unvaccinated employees at least weekly for COVID-19 by February 15. The weekly testing impacts all non-exempt employees who “work onsite or interact in person with members of...
by Jordana Choucair | Jan 12, 2022 | Life Sciences
Medicare officials said the program should restrict coverage of Aduhelm, Biogen’s Alzheimer’s drug, to patients participating in randomized, controlled clinical trials. The agency made its decision after reviewing scientific evidence and various stakeholder opinions...
by Jordana Choucair | Jan 12, 2022 | Life Sciences
The federal government ordered another 600,000 doses of GlaxoSmithKline PLC and Vir Biotechnology Inc.’s monoclonal antibody treatment for COVID-19. The drugmakers plan to deliver the treatment, which is the only one thought to work against the Omicron variant,...
Recent Comments